Prior coronary artery bypass graft surgery patients undergoing diagnostic coronary angiography have multiple uncontrolled coronary artery disease risk factors and high risk for cardiovascular events

Heart and Vessels

Volumn 24, Issue 4, 2009, Pages 241-246

  Boatman, Dustin M ^a,b   Saeed, Bilal ^a,b   Varghese, Indu ^a,b   Peters, Calvin T ^a,b   Daye, Jad ^a,b   Haider, Aman ^a,b   Roesle, Michele ^a,b   Banerjee, Subhash ^a,b   Brilakis, Emmanouil S ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

Author keywords

Coronary angiography; Coronary artery bypass; Coronary disease; Risk factors

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ACUTE CORONARY SYNDROME; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE CONTROL; DYSLIPIDEMIA; FEMALE; FOLLOW UP; GRAFT PATENCY; HEART MUSCLE REVASCULARIZATION; HOSPITALIZATION; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OBESITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SMOKING;

AGED; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DYSLIPIDEMIAS; HUMANS; HYPERTENSION; HYPOGLYCEMIC AGENTS; INCIDENCE; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; OBESITY; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SMOKING; TEXAS; TIME FACTORS; TREATMENT OUTCOME; VETERANS;

EID: 68249146111     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-008-1114-1     Document Type: Article

References (33)

1. Bradshaw PJ, Jamrozik K, Le M, Gilfillan I, Thompson PL (2002) Mortality and recurrent cardiac events after coronary artery bypass graft: Long term outcomes in a population study. Heart 88:488-494
2. Wattanakit K, Folsom AR, Chambless LE, Nieto FJ (2005) Risk factors for cardiovascular event recurrence in the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J 149:606-612
3. Kjoller-Hansen L, Steffensen R, Grande P (2000) The Angiotensin-converting Enzyme Inhibition Post Revascularization Study (APRES). J Am Coll Cardiol 35:881-888
4. Chen J, Radford MJ, Wang Y, Marciniak TA, Krumholz HM (2000) Are beta-blockers effective in elderly patients who undergo coronary revascularization after acute myocardial infarction? Arch Intern Med 160:947-952
5. Mangano DT (2002) Aspirin and mortality from coronary bypass surgery. N Engl J Med 347:1309-1317
6. Knatterud GL, Rosenberg Y, Campeau L, Geller NL, Hunninghake DB, Forman SA, Forrester JS, Gobel FL, Herd JA, Hickey A, Hoogwerf BJ, Terrin ML, White C (2000) Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG Investigators. Circulation 102:157-165
7. Goyal A, Alexander JH, Hafley GE, Graham SH, Mehta RH, Mack MJ, Wolf RK, Cohn LH, Kouchoukos NT, Harrington RA, Gennevois D, Gibson CM, Califf RM, Ferguson TB Jr, Peterson ED (2007) Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery. Ann Thorac Surg 83:993-1001
8. DeBakey ME, Glaeser DH (2000) Patterns of atherosclerosis: Effect of risk factors on recurrence and survival-analysis of 11,890 cases with more than 25-year follow-up. Am J Cardiol 85:1045-1053
9. Rosendorff C, Black HR, Cannon CP, Gersh BJ, Gore J, Izzo JL, Jr., Kaplan NM, O'Connor CM, O'Gara PT, Oparil S (2007) Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation 115:2761-2788
10. American Diabetes Association (2007) Standards of medical care in diabetes - 2007. Diabetes Care 30Suppl 1:S4-S41
11. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC, Jr., Stone NJ (2004) Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110:227-239
12. Adult Treatment Panel III (2002) Third Report of the National Cholesterol Education program (NCEP) Expert panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106:3143-3421
13. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM (2006) Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295:1549-1555
14. Campeau L, Hunninghake DB, Knatterud GL, White CW, Domanski M, Forman SA, Forrester JS, Geller NL, Gobel FL, Herd JA, Hoogwerf BJ, Rosenberg Y (1999) Aggressive cholesterol lowering delays saphenous vein graft atherosclerosis in women, the elderly, and patients with associated risk factors. NHLBI post coronary artery bypass graft clinical trial. Post CABG Trial Investigators. Circulation 99:3241-3247
15. Brunzell JD, Davidson M, Furberg CD, Goldberg RB, Howard BV, Stein JH, Witztum JL (2008) Lipoprotein management in patients with cardiometabolic risk: Consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation. J Am Coll Cardiol 51:1512-1524
16. Shah SJ, Waters DD, Barter P, Kastelein JJ, Shepherd J, Wenger NK, DeMicco DA, Breazna A, LaRosa JC (2008) Intensive lipidlowering with atorvastatin for secondary prevention in patients after coronary artery bypass surgery. J Am Coll Cardiol 51:1938-1943
17. Ong KL, Cheung BM, Man YB, Lau CP, Lam KS (2007) Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension 49:69-75
18. Cheng EM, Asch SM, Brook RH, Vassar SD, Jacob EL, Lee ML, Chang DS, Sacco RL, Hsiao AF, Vickrey BG (2007) Suboptimal control of atherosclerotic disease risk factors after cardiac and cerebrovascular procedures. Stroke 38:929-934
19. MMWR (2006) Tobacco use among adults - United States, 2005. Morb Mortal Wkly Rep 55:1145-1148
20. Wagner BD, Grunwald GK, Rumsfeld JS, Hill JO, Ho PM, Wyatt HR, Shroyer AL (2007) Relationship of body mass index with outcomes after coronary artery bypass graft surgery. Ann Thorac Surg 84:10-16
21. Fiore MC (2000) Treating tobacco use and dependence: An introduction to the US Public Health Service Clinical Practice Guideline. Respir Care 45:1196-1199
22. Thompson W, Wang H, Xie M, Kolassa J, Rajan M, Tseng CL, Crystal S, Zhang Q, Vardi Y, Pogach L, Safford MM (2005) Assessing quality of diabetes care by measuring longitudinal changes in hemoglobin A1c in the Veterans Health Administration. Health Serv Res 40:1818-1835
23. Saaddine JB, Cadwell B, Gregg EW, Engelgau MM, Vinicor F, Imperatore G, Narayan KM (2006) Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002. Ann Intern Med 144:465-474
24. Wang Y, Beydoun MA (2007) The obesity epidemic in the United States - gender, age, socioeconomic, racial/ethnic, and geographic characteristics: A systematic review and meta-regression analysis. Epidemiol Rev 29:6-28
25. Christakis NA, Fowler JH (2007) The spread of obesity in a large social network over 32 years. N Engl J Med 357:370-379
26. Bays HE, Chapman RH, Grandy S (2007) The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: Comparison of data from two national surveys. Int J Clin Pract 61:737-747
27. Okrainec K, Platt R, Pilote L, Eisenberg MJ (2005) Cardiac medical therapy in patients after undergoing coronary artery bypass graft surgery: A review of randomized controlled trials. J Am Coll Cardiol 45:177-184
28. Mehta RH, Honeycutt E, Peterson ED, Granger CB, Halabi AR, Shaw LK, Smith PK, Califf RM, Harrington RA, Sketch MH Jr (2006) Impact of internal mammary artery conduit on long-term outcomes after percutaneous intervention of saphenous vein graft. Circulation 114:I396-I401
29. Suematsu Y, Nakano K, Sasako Y, Kobayashi J, Kitamura S, Takamoto S (2000) Conventional coronary artery bypass grafting in patients with total occlusion of the internal carotid artery. Heart Vessels 15:256-262
30. Charniot JC, Zerhouni K, Kambouchner M, Martinod E, Vignat N, Azorin J, Gandjbakhch I, Artigou JY (2007) Persistent symptomatic pleural effusion following coronary bypass surgery: Clinical and histologic features, and treatment. Heart Vessels 22:16-20
31. Catakoglu AB, Aytekin S, Sener M, Kurtoglu H, Celebi H, Demiroglu IC, Aytekin V (2007) Impact of anemia on nonfatal coronary events after percutaneous coronary interventions. Heart Vessels 22:383-388
32. Mehta RH, Honeycutt E, Shaw LK, Glower D, Harrington RA, Sketch MH Jr (2006) Clinical correlates of long-term mortality after percutaneous interventions of saphenous vein grafts. Am Heart J 152:801-806
33. Greenberg JA (2002) Hypothesis - the J-shaped follow-up relation between mortality risk and disease risk-factor is due to statistical confounding. Med Hypotheses 59:568-576